GANX
Gain Therapeutics Inc
NASDAQ: GANX · HEALTHCARE · BIOTECHNOLOGY
$1.76
-4.86% today
Updated 2026-04-29
Market cap
$83.70M
P/E ratio
—
P/S ratio
255.50x
EPS (TTM)
$-0.61
Dividend yield
—
52W range
$1 – $4
Volume
0.7M
Gain Therapeutics Inc (GANX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-155.70%
ROA
-67.00%
Debt/equity
0.03x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $20609.00 | $-1.11M | 100.00% | -4,989.66% | -5,364.36% |
| 2019 | $41301.00 | $-2.19M | 100.00% | -5,084.89% | -5,310.88% |
| 2020 | $28881.00 | $-3.58M | 100.00% | -12,047.54% | -12,387.67% |
| 2021 | $133928.00 | $-13.89M | -5,249.31% | -10,323.59% | -10,371.70% |
| 2022 | $132640.00 | $-17.59M | -6,114.63% | -13,402.48% | -13,262.02% |
| 2023 | $55180.00 | $-22.27M | 100.00% | -40,328.26% | -40,354.33% |
| 2024 | $0.00 | $-20.41M | — | — | — |
| 2025 | $0.00 | $-20.16M | — | — | — |